NO20073088L - Deacylering av LPS i gramnegative bakterier - Google Patents

Deacylering av LPS i gramnegative bakterier

Info

Publication number
NO20073088L
NO20073088L NO20073088A NO20073088A NO20073088L NO 20073088 L NO20073088 L NO 20073088L NO 20073088 A NO20073088 A NO 20073088A NO 20073088 A NO20073088 A NO 20073088A NO 20073088 L NO20073088 L NO 20073088L
Authority
NO
Norway
Prior art keywords
gram
lps
negative
negative bacteria
deacylation
Prior art date
Application number
NO20073088A
Other languages
English (en)
Other versions
NO340331B1 (no
Inventor
Johannes Petrus Mari Tommassen
Peter Andre Van Der Ley
Jeroen Johannes Gerar Geurtsen
Original Assignee
Nvi Nl Vaccininst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nvi Nl Vaccininst filed Critical Nvi Nl Vaccininst
Publication of NO20073088L publication Critical patent/NO20073088L/no
Publication of NO340331B1 publication Critical patent/NO340331B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse tilveiebringer Gram-negative polypeptider som oppviser lipid A 3-0-deacylaseaktivitet og som er i stand til å modifisere og/eller detoksifisere gram-negativ LPS. Foreliggende oppfinnelse tilveiebringer også Gram-negative bakterier, Gram-negative bakterielle lipopolysakkarider (LPS) og sammensetninger som omfatter LPS, som er tilveiebrakt med eller behandlet med 3-0-deacylaseaktivitet i samsvar med oppfinnelsen og som kan anvendes for farmasøytiske og veterinæriske formål, spesielt for fremstilling av helcelle eller acellulære vaksiner mot patogent Gram-negative så som Bordetella pertussis, Bordetella parapertussis og Bordetella bronchiseptica.
NO20073088A 2004-12-17 2007-06-18 Deacylering av LPS i gramnegative bakterier NO340331B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078445 2004-12-17
PCT/NL2005/050081 WO2006065139A2 (en) 2004-12-17 2005-12-16 Deacylation of lps in gram negative bacteria

Publications (2)

Publication Number Publication Date
NO20073088L true NO20073088L (no) 2007-09-17
NO340331B1 NO340331B1 (no) 2017-04-03

Family

ID=34928754

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073088A NO340331B1 (no) 2004-12-17 2007-06-18 Deacylering av LPS i gramnegative bakterier

Country Status (15)

Country Link
US (1) US8048433B2 (no)
EP (1) EP1828378B1 (no)
JP (1) JP5378685B2 (no)
CN (1) CN101203605B (no)
AU (1) AU2005317304B2 (no)
BR (1) BRPI0519923A8 (no)
CA (1) CA2590906C (no)
DK (1) DK1828378T3 (no)
ES (1) ES2493440T3 (no)
MX (1) MX2007007288A (no)
NO (1) NO340331B1 (no)
NZ (1) NZ555889A (no)
PL (1) PL1828378T3 (no)
PT (1) PT1828378E (no)
WO (1) WO2006065139A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9296995B2 (en) * 2007-03-26 2016-03-29 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Vaccines against Bordetella pertussis based on LPS glycosyltransferase mutants
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
KR102125600B1 (ko) 2013-06-04 2020-06-23 페트르 젠나디에비치 아파린 개질된 내독성 세균 지질다당류(변형체), 개질된 지질다당류들(변형체들)의 조합물, 및 이를 함유한 백신(변형체) 및 약제 조성물(변형체)
US11052142B2 (en) 2013-06-04 2021-07-06 Petr G. Aparin Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
CN105555304A (zh) 2013-08-05 2016-05-04 葛兰素史密丝克莱恩生物有限公司 联合免疫原性组合物
WO2015179270A2 (en) 2014-05-19 2015-11-26 Board Of Regents, The University Of Texas System Combinatorial platform for the display of surface adjuvants and antigens
CN104388368B (zh) * 2014-10-30 2017-02-15 四川农业大学 一株低内毒素大肠杆菌原核表达工程菌突变株及构建方法
US11389520B2 (en) * 2016-01-28 2022-07-19 Intravacc B.V. Modified tetra-acylated neisserial LPS
CN105567620B (zh) * 2016-01-29 2019-03-19 江南大学 一株产减毒类脂A的Cronobacter sakazakii突变株及其应用
CN105695540A (zh) * 2016-03-18 2016-06-22 辽宁成大生物股份有限公司 一种革兰氏阴性菌胞壁抗原的制备方法
CA3055757A1 (en) * 2017-03-13 2018-09-20 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Bordetella vaccines comprising lps with reduced reactogenicity
US11744884B2 (en) * 2017-05-15 2023-09-05 University Of Maryland, Baltimore Live Salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof
CN111433348B (zh) * 2017-12-04 2024-07-02 Intravacc有限责任公司 一种改良的生产外膜囊泡的方法
CN116438193A (zh) 2020-09-04 2023-07-14 Intravacc有限责任公司 OmpA突变增强百日咳博德特氏菌中OMV产生
EP4169513A1 (en) 2021-10-19 2023-04-26 GlaxoSmithKline Biologicals S.A. Adjuvant composition comprising sting agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH650681A5 (en) 1981-08-14 1985-08-15 Dso Pharmachim Whooping cough vaccine
KR0168039B1 (ko) * 1987-09-04 1999-01-15 로버트 디. 웨스트 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
EP0656948B1 (en) * 1992-08-18 2004-03-31 Dimminaco Ag Bordetella bronchiseptica vaccine
EP1234579A1 (en) * 1995-05-04 2002-08-28 Aventis Pasteur Limited Acellular Pertussis Vaccines and Methods of Preparation Thereof
US6887483B2 (en) 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria
EP0971739B1 (en) * 1997-04-01 2004-10-06 Corixa Corporation Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
CA2264970A1 (en) 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
AU762369B2 (en) * 1998-11-03 2003-06-26 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur LPS with reduced toxicity from genetically modified gram negative bacteria
US6531131B1 (en) * 1999-08-10 2003-03-11 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for Neisseria meningitidis
WO2002085295A2 (en) * 2001-04-20 2002-10-31 The University Of Iowa Research Foundation Methods and compositions for the modulation of biofilm formation

Also Published As

Publication number Publication date
US20080274145A1 (en) 2008-11-06
EP1828378A2 (en) 2007-09-05
AU2005317304B2 (en) 2011-06-23
DK1828378T3 (da) 2014-09-01
MX2007007288A (es) 2008-02-25
BRPI0519923A8 (pt) 2018-01-23
CN101203605B (zh) 2016-01-27
JP2008523805A (ja) 2008-07-10
EP1828378B1 (en) 2014-06-11
WO2006065139A3 (en) 2006-10-19
CA2590906C (en) 2017-01-03
WO2006065139A2 (en) 2006-06-22
CN101203605A (zh) 2008-06-18
JP5378685B2 (ja) 2013-12-25
US8048433B2 (en) 2011-11-01
PL1828378T3 (pl) 2014-10-31
NO340331B1 (no) 2017-04-03
ES2493440T3 (es) 2014-09-11
CA2590906A1 (en) 2006-06-22
BRPI0519923A2 (pt) 2009-08-11
AU2005317304A1 (en) 2006-06-22
PT1828378E (pt) 2014-10-10
NZ555889A (en) 2009-07-31

Similar Documents

Publication Publication Date Title
NO20073088L (no) Deacylering av LPS i gramnegative bakterier
CY1119753T1 (el) Λυσινικη αλφα αζτρεοναμη
BRPI0411505A (pt) uso de um composto, método para modular a resposta imune de um indivìduo, composição farmacêutica, vacina, complexo, e, kit para a captura de uma molécula biologicamente ativa
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
NO20072906L (no) Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
BR9900972A (pt) Uso de uma associação de lactobacilos para a preparação de uma composição para tratamento de vaginoses e vaginites, e composições farmacêuticas assim preparadas.
NO20064584L (no) Tetrahydropyridoindolderivater
SG164344A1 (en) Immunogens from uropathogenic escherichia coli
DK1648505T3 (da) Quil A-fraktion med lav toksicitet og anvendelse deraf
WO2007084633A3 (en) Viable non-toxic gram negative bacteria
NO20075069L (no) Vaksiner mot Clamydia infeksjon
DK2561880T3 (da) Mælkesyrebakterier som priobiotiske stammer og sammensætninger dermed
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
JP2008523805A5 (no)
DK2054431T3 (da) Konformere af bakterielle adhæsiner
BRPI0518080A (pt) bactéria transformada ou uma progênie da mesma, método para transformar uma bactéria, mycobacterium transformada ou uma progênie da mesma e vacina compreendendo uma mycobacterium transformada ou uma progênie da mesma
NO20062878L (no) Isoflavonoidpromedikamenter, terapeutiske sammensetninger derav og terapeutiske fremgangsmater som innbefatter de samme
DE602005016548D1 (de) Silikonvesikel
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
IL156942A0 (en) Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
ATE550647T1 (de) Auflösungszusammensetzung zur untersuchung von arzneistofflöslichkeit
ATE544471T1 (de) Zusammensetzung mit iscom-teilchen und lebenden mikroorganismen
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees